Stock Events

Stock Events

Monopar Therapeutics (MNPR) Q2 2023 Earnings

10AugConfirmed

Nov 22

Q4 2022

Q1 2023

Q2 2023

-0.22

-0.2

-0.18

-0.16

Details

Expected EPS

-0.18

Actual EPS

-0.16

Surprise EPS

0.02

Surprise Percent

+11.11%

Description

Monopar Therapeutics (MNPR) has reported earnings of -0.16 per share for Q2 2023.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.